Edwards Lifesciences (EW) EPS (Weighted Average and Diluted) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.10% |
| Dec 31, 2025 | -25.83% |
| Sep 30, 2025 | -0.78% |
| Jun 30, 2025 | 36.85% |
| Mar 31, 2025 | 4.48% |
| Dec 31, 2024 | 8.12% |
| Sep 30, 2024 | 64.18% |
| Jun 30, 2024 | 9.93% |
| Mar 31, 2024 | 8.26% |
| Dec 31, 2023 | 82.66% |
| Sep 30, 2023 | -12.30% |
| Jun 30, 2023 | -17.65% |
| Mar 31, 2023 | -12.59% |
| Dec 31, 2022 | 131.85% |
| Sep 30, 2022 | -6.99% |
| Jun 30, 2022 | -5.45% |
| Mar 31, 2022 | -11.06% |
| Dec 31, 2021 | -6.20% |
| Sep 30, 2021 | -3.64% |
| Jun 30, 2021 | 6.10% |
| Mar 31, 2021 | -3.93% |
| Dec 31, 2020 | -5.20% |
| Sep 30, 2020 | -0.75% |
| Jun 30, 2020 | -19.06% |
| Mar 31, 2020 | -2.64% |
| Dec 31, 2019 | -2.52% |
| Sep 30, 2019 | -0.46% |
| Jun 30, 2019 | -31.66% |
| Mar 31, 2019 | 6.85% |
| Dec 31, 2018 | -46.43% |
| Sep 30, 2018 | 9.28% |
| Jun 30, 2018 | 10.26% |
| Mar 31, 2018 | -4.99% |
| Dec 31, 2017 | -15.02% |
| Sep 30, 2017 | 6.38% |
| Jun 30, 2017 | 8.57% |
| Mar 31, 2017 | 14.02% |
| Dec 31, 2016 | 6.61% |
| Sep 30, 2016 | 8.61% |
| Jun 30, 2016 | 3.86% |
| Mar 31, 2016 | 4.48% |
| Dec 31, 2015 | 3.46% |
| Sep 30, 2015 | 6.19% |
| Jun 30, 2015 | 1.22% |
| Mar 31, 2015 | 6.96% |
| Dec 31, 2014 | 4.56% |
| Sep 30, 2014 | -6.93% |
| Jun 30, 2014 | 44.13% |